Fact based stock research
Shanxi Zhendong Pharmaceutical (SZSE:300158)

CNE100000YR9



Due to the geopolitical instabilities, research on companies located in authoritarian regimes has been discontinued. Research at Obermatt is limited to companies in democracies as measured by The Economist Intelligence Unit Democracy Index.



Shanxi Zhendong Pharmaceutical stock research in summary

zdjt.com


There is no stock research analysis by the purely financial fact-based Obermatt method for: Shanxi Zhendong Pharmaceutical (SZSE:300158), Pharmaceuticals, China. Contact us if you would like research on this stock.


Latest Obermatt Ranks


Country China
Industry Pharmaceuticals
Index
Size class Medium

August 16, 2018. Stock data may be delayed. Login to get the most recent research.

Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Shanxi Zhendong Pharmaceutical from August 16, 2018.

We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.